Innocan Pharma Highlights Breakthrough Narrative Review on Liposomal Synthetic CBD for Chronic Pain: A Novel Non-Opioid Analgesic Approach

Innocan Pharma Corporation Canada Israel Ontario

View original content:https://www.prnewswire.co.uk/news-releases/innocan-pharma-highlights-breakthrough-narrative-review-on-liposomal-synthetic-cbd-for-chronic-pain-a-novel-non-opioid-analgesic-approach-302480990.html